Neu-P11

DRUG3 trials

Sponsors

Neurim Pharmaceuticals Ltd., Ludwig-Maximilians - University of Munich

Conditions

Diarrhea- Irritable Bowel SyndromeInsomniaPrimary Insomnia

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia

CompletedNCT01114126

Neurim Pharmaceuticals Ltd.Insomnia

Start: 2010-04-30End: 2011-04-30Target: 24Updated: 2011-04-07

Phase 2

Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients

CompletedNCT01489969

Neurim Pharmaceuticals Ltd.Primary Insomnia

Start: 2011-12-31End: 2013-01-31Updated: 2018-06-06

Unknown Phase

The Effect of Neu-P11 on Symptoms in Patients With D-IBS

CompletedNCT01558284

Ludwig-Maximilians - University of MunichDiarrhea- Irritable Bowel Syndrome

Start: 2012-02-29End: 2014-02-28Updated: 2014-02-05